DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/ecf487/rapid_tests_and_po) has announced the addition of the "Rapid Tests and Point of Care Market to 2017 - Clinical Chemistry Tests to be the Major Revenue Generator" report to their offering.

GBI Research's report, Rapid Tests and Point of Care Market to 2017 - Clinical Chemistry Tests to be the Major Revenue Generator, provides key data, information and analysis on the global rapid tests and point of care (POC) market. The report provides information on the market landscape, the competitive landscape and market trend information on three rapid tests and POC market categories: clinical chemistry rapid tests and POC, immunochemistry rapid tests, and hematology rapid tests. The report provides comprehensive information on the key trends affecting these categories and key analytical content on the market's dynamics.

The report also provides profiles of the major companies operating in the rapid tests and POC market and a detailed analysis of the pipeline products in each category. Furthermore, the report reviews the details of important merger and acquisition deals that have taken place in the rapid tests and POC market over the past four years. The report is compiled using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research's team of industry experts.

Rapid Tests and Point of Care Market Forecast to Increase at a CAGR of 7% During the Period 2010 - 2017

The global rapid tests and point of care market was valued at $4.7 billion in 2010 and is forecast to grow to $7.4 billion by 2017, registering a compound annual growth rate (CAGR) of 7% during the period 2010 - 2017.

Companies Mentioned:

For more information visit http://www.researchandmarkets.com/research/ecf487/rapid_tests_and_po

Link:
Research and Markets: Rapid Tests and Point of Care Market to 2017 - Clinical Chemistry Tests to be the Major Revenue ...